Distributor inventory | Tablet
Gliclazide 80 mg + Metformin Hydrochloride 500 mg (tablet)
Type 2 diabetes mellitus (to improve blood sugar control when diet and exercise alone are not sufficient)
Gliclazide (a sulfonylurea) increases insulin release from the pancreas and helps lower blood glucose. Metformin (a biguanide) decreases glucose production in the liver and improves insulin sensitivity, reducing blood sugar levels.
Oral tablet. Take exactly as prescribed, usually with meals to reduce stomach upset. Swallow whole with water; do not crush/chew unless advised. Regularly monitor blood glucose; do not skip meals to avoid low sugar.
Common side effects of GLYCIMET 3C 80/500MG TAB may include:
Risk of hypoglycaemia (higher with missed meals, heavy exercise, alcohol, or other antidiabetics); carry glucose/sugar source. Metformin may rarely cause lactic acidosis—seek urgent care for rapid breathing, severe weakness, abdominal pain, or unusual sleepiness. Use with caution in kidney or liver impairment and in the elderly; kidney function should be assessed periodically. Temporarily stop metformin before/after iodinated contrast procedures and major surgery as advised by doctor. Not for type 1 diabetes or diabetic ketoacidosis.
